Effect of Natural Polyphenols on Breast Cancer Chemoprevention and Treatment

Marzia Sichetti1, Martina Giuseffi1, Eugenia Giglio1

  • 1Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), Rionero in Vulture, Italy.

Insights

Curcumin, resveratrol, and polydatin show promise as natural compounds against breast cancer. These polyphenols exhibit anticancer effects, improving drug efficacy and reducing resistance, tumor growth, and metastasis.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Breast cancer is a leading global malignancy in women, with drug resistance and metastasis posing significant challenges.
  • Natural products offer a valuable source for novel small-molecule anticancer drugs due to their low toxicity and diverse structures.
  • Polyphenols are recognized for their potential in breast cancer prevention and as adjuncts to conventional therapies.

Purpose of the Study:

  • To review the antitumor effects of curcumin, resveratrol, and polydatin on breast cancer.
  • To synthesize findings from in vitro and preclinical studies on these natural compounds.
  • To highlight their mechanisms of action in combating breast cancer.

Main Methods:

  • Literature search of major scientific databases.
  • Inclusion of in vitro and preclinical studies with robust scientific evidence.
  • Focus on studies reporting protective effects in breast cancer treatment.

Main Results:

  • Curcumin, resveratrol, and polydatin demonstrate antioxidant, anti-inflammatory, and anticancer properties.
  • These compounds enhance drug efficacy, reduce chemoresistance, inhibit angiogenesis, and suppress tumor growth.
  • They induce apoptosis, autophagy, and cell cycle arrest via multiple molecular pathways.

Conclusions:

  • Curcumin, resveratrol, and polydatin exhibit significant potential as therapeutic agents or adjuncts in breast cancer treatment.
  • Their multifaceted mechanisms involve modulating key signaling pathways like NF-κB, PI3K/Akt/mTOR, and MAPK.
  • Further research into these natural compounds could lead to novel strategies for overcoming breast cancer drug resistance and metastasis.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K